Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

Prepare for a seismic shift in the conversation around medicine and health as PHARMAGEDDON, a provocative new documentary, ...

Sun Pharmaceutical Industries announces a USD 100 million investment to commercialize new speciality products, strengthening ...

South Korean pharmaceutical and biotech companies are on track to exceed 10 trillion won ($7.5 billion) in licensing revenues ...

FDA approvals for new biosimilars like Starjemza and Hadlima enhance treatment options, addressing urgent needs for ...

The U.S. federal court ruling that President Trump had overstepped his authority on imposing tariffs marked a clear setback ...

The U.S. is proposing major policy changes to its healthcare sector, including imposing tariffs on global manufacturers. Click to read.

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

FRANKFURT, Germany, May 29, 2025 /CNW/ -- Qualifyze, already the global leader in third-party audit services for the ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

The administration of US President Donald Trump has taken a series of actions since January, 2025 that directly threaten the ...